Skip to content

Cognitive Stimulation in Elderly Individuals at Risk to Develop Dementia (Allena-Mente).

Effects of Cognitive Stimulation in Elderly Individuals at Risk to Develop Dementia: a Randomized Controlled Trial (Allena-Mente).

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01793493
Acronym
Allena-Mente
Enrollment
121
Registered
2013-02-15
Start date
2011-03-31
Completion date
2015-06-30
Last updated
2023-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects With Family History for Dementia, Mild Cognitive Impairment

Keywords

Mild Cognitive Impairment, Cognitive Stimulation, Aging, Elderly, Randomized Controlled Trial

Brief summary

The Allena-Mente study is a randomized, controlled, single-blind trial assessing the efficacy of cognitive stimulation (CS) compared to an active control group, participating to sanitary education lessons (AC). This non-pharmacological intervention is delivered to Mild Cognitive Impairment (MCI) and cognitively healthy individuals with first-degree relative with dementia (NDFAM).

Detailed description

The experimental protocol was set up with a pilot study on healthy elderly individuals. Data from this pilot study will be excluded from the statistical analysis. Sample size: a priori power analysis was performed to evaluate the sample size required for the study. MCI and NDFAM were considered separately for sample size calculation. For power calculation a two-tailed test was used and a significance level (α) and test power (1-β) were set at 0.05 and 0.8/0.9, respectively. Randomization: The individuals belonging to MCI and NDFAM subgroup were randomly assigned to CS or AC group. The randomization was performed by a statistician blind to participants characteristics using the Random Allocation Software. Allocation ratio was set at 1:1, stratification was performed for birth cohort (≤1937 and ≥1938), education level (years of education ≤5 years and \>5 years). Participants provided written informed consent before study participation.

Interventions

OTHERCognitive stimulation

Participants are pooled in small groups (6-8 individuals). Each group participates to ten twice weekly meetings. Each CS session is run by one trained operator. One observer participates to the sessions to guarantee homogeneity between different operators. Exercises are structured with an increasing cognitive complexity and are tailored to the characteristics of the group. Meetings (each lasting about 2 hours) have a common structure: * body awakening (10 minutes) * cognitive stimulation (1 hour and a half) scheduled as follow: * temporospatial orientation * attentional abilities * one of the following cognitive areas: language, executive functions, verbal and visual memory (encoding, consolidation, retrieval)

OTHERSanitary education

Participants attend two weekly meetings (for a total of 3 hours) focused on lifestyle education and brain functioning.

Sponsors

Alzheimer Federation Italy
CollaboratorOTHER
Camillo Golgi Geriatric Institute
CollaboratorOTHER
University of Pavia
CollaboratorOTHER
Mario Negri Institute for Pharmacological Research
CollaboratorOTHER
Fondazione Golgi Cenci
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
70 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Positive diagnosis for mild cognitive impairment (MCI) according to Petersen's criteria; * Cognitively healthy elderly individuals, having at least one first-degree relative affected by dementia (Alzheimer's Disease, pre-senile and senile dementia, vascular dementia) (NDFAM).

Exclusion criteria

* (Major physical illness) Compromission of motor performance of lower and upper limbs * Medical conditions leading to clinical instability; * Therapies that reduce cognitive and communicative abilities and consciousness; * Perceptual disorders (sight, hearing) * Language disorders * Education level lower than 3 years * Psychiatric and behavioral disorders * Addiction to drugs or alcohol

Design outcomes

Primary

MeasureTime frameDescription
Long-term change from Baseline in Mini Mental State Examination (MMSE)baseline and up to 4 yearsMini Mental State examination (MMSE) is a brief test of mental status and cognitive function, commonly used in clinical research to screen global cognitive functioning.

Secondary

MeasureTime frameDescription
Change from Baseline in Mini Mental State Examination at 2-weeks after the interventionbaseline, two-weeks after the interventionMMSE is a brief test of mental status and cognitive function, commonly used in clinical research to screen global cognitive functioning.
Change from Baseline in Montreal Cognitive Assessment (MoCA) at 2-weeks after the interventionbaseline, two-weeks after the interventionMoCA is a brief cognitive screening tool with a high sensitivity and specificity for detecting MCI in individuals performing in the normal range on the MMSE (avoiding ceiling effect).
Change from Baseline in Corsi test at 2-weeks after the interventionbaseline, two-weeks after the interventionCorsi test evaluates visual-spatial short-term memory. We used this test to implement non-verbal memory in our neuropsychological test battery
Change from Baseline in Walking While Talking Dual Task at 2-weeks after the interventionbaseline, two-weeks after the interventionWalking speed measures the ability to perform a dual action task. Single task: participants walk back and forth along an indicated distance of 5 meters with no pausing. Dual task: participants perform the same movement as in the single task while listing personal names in a loud voice (female names for men and male names for women) The span between time needed to perform the dual and the single task is registered.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026